Novel penetration enhancers for skin applications: A review

Current Drug Delivery

Volumn 9, Issue 2, 2012, Pages 219-230

  Parhi, Rabinarayan ^a   Suresh, Padilama ^a   Mondal, Sumant ^a   Kumar, Posa Mahesh ^a  

^a GITAM UNIVERSITY   (India)

Author keywords

Bilipid layer; Penetration enhancers; Soft enhancement for percutaneous absorption; Stratum corneum

Indexed keywords

1 ALKYL 3 BETA DEXTRO GLUCOPYRANOSYL 1,1,3,3 TETRAMETHYL DISILOXANE; 2 N NONYL 1,3 DIOXOLANE; 5 (DODECYLOXYCARBONYL)PENTYLAMMONIUM 5 (DODECYLOXYCARBONYL)PENTYLCARBAMATE; ALKYLDISILOXANE; ALOE VERA EXTRACT; BENZYL DIMETHYL DODECYL AMMONIUM CHLORIDE; BROMO IMINOSULFURANE; CAPSAICIN; CARBAMIC ACID; CINNAMALDEHYDE; CINNAMIC ACID; CLOVE OIL; DIMETHYL SULFOXIDE; INDOMETACIN; MINOXIDIL; N ACETYLE PROLINATE ESTER; N LAUROYL SARCOSINE; N,N DIMETHYLACETAMIDE; N,N DIMETHYLFORMAMIDE; NONIVAMIDE; OCTYL ACETYLE PROLINATE; PENETRATION ENHANCING AGENT; PENTYL N ACETYLE PROLINATE; PHENAZONE; PHENYL PIPERAZINE; SODIUM LAURETH SULFATE; SORBITAN OLEATE; STYRENE; TRANSKARBAM; UNCLASSIFIED DRUG; UNINDEXED DRUG;

DERMIS; DRUG FORMULATION; EPIDERMIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN ABSORPTION; STRATUM CORNEUM; SUBCUTANEOUS TISSUE; TRANSDERMAL DRUG ADMINISTRATION;

EID: 84857864623     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720112800234585     Document Type: Review

References (90)

1. Anjos, J.L.V.; Neto, D.S.; Alonso, A. Effects of 1,8-cineole on the dynamics of lipids and proteins of stratum corneum. Int. J. Pharm., 2007, 345, 81-87.
2. Shin, S.C.; Cho, C.W.; Choi, H.K. Permeation of Piroxicam from the poloxamer gels. Drug Dev. Ind. Pharm., 1999, 25, 273-278.
3. Mills, P.C.; Cross, S.E. Transdermal drug delivery: Basic principles for the veterinarian. Veter. J., 2006, 172, 218-233.
4. Lima, P.F.C.; Liu, X.Y.; Kang, L.; Ho, P.C.L.; Chan, Y.W.; Chan, S.Y. Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol. Int. J. Pharm., 2006, 311, 157-164.
5. Walters, K.A.; Roberts, M.S. Structure and Function of Skin-In Dermatological and Transdermal Formulation. Mercel Dekker INC: New York, 2002.
6. Koizumi, A.; Fujii, M.; Kondoh, M.; Watanabe, Y. Effect of N- methyl-2-pyrrolidone on skin permeation of estradiol. Eur. J. Pharm. Biopharm., 2004, 57, 473-478.
7. Mitragotr, S.; Blankschetein, D.; Langer, R. Ultrasound-mediated transdermal protein delivery. Science, 1995, 269, 850-853.
8. Guy, R.H.; Kalia, Y.N.; Delgado-Charro, M.B.; Merino, V.; Lopez, A.; Marro, D. Iontophoresis: Electrorepulsion and electroosmosis. J. Control. Release, 2000, 64, 129-132.
9. Finnin, B.C.; Morgan, T.M. Transdermal penetration enhancers: Applications, limitation and potential. J. Pharm. Sci., 1999, 88, 955-958.
10. Williams, A.C.; Barry, B.W. Skin absorption enhancers. Crit. Rev. Ther. Drug Carr. Syst., 1992, 9, 305-353.
11. Zbytovska, J.; Vavrova, K.; Kiselev, M.A.; Lessieur, P.; Wartewig, S.; Neubert, R.H.H. The effects of transdermal permeation en hancers on thermotropic phase behaviour of a stratum corneum lipid model. Colloids Surfaces A: Physicochem. Eng. Aspects, 2009, 351, 30-37.
12. Barry, B.W. Dermatological Formulations: Percutaneous Absorption. Marcel Dekker: New York, 1983.
13. Robinson, M.K.; Perkins, M.A. A strategy for skin irritation testing. Am. J. Contact. Dermat., 2002, 13, 21-29.
14. Jimbow, K.; Lee, S.K.; King, M.G.; Hara, H.; Chen, H.; Dakour, J.; Marusyk, H. Melanin pigments and melanosomal proteins as differentiation markers unique to normal and neoplastic melanocytes. J. Investi. Dermat., 1993, 100, 259-268.
15. Aiba, S.; Katz, S.I. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J. Immunology, 1990, 145, 2791-2796.
16. Tachibana, T. The Merkel cell: recent findings and unresolved problems. Arch. Histo. Cyto., 1995, 58, 379-396.
17. Lavker, R.M.; Sun, T.T. Heterogeneity in epidermal basal keratino-cytes: morphological and functional correlations. Science, 1982, 215, 1239-1241.
18. Borradori, L.; Sonnenberg, A. Structure and function of hemides-mosomes: more than simple adhesion complexes. J. Invest. Der-mat., 1999, 112, 411-418.
19. Michaels, A.S.; Chandrasekaran, S.K.; Shaw, J.E. Drug permeation through human skin. Theory and in vitro experimental measurement. Am. Inst. Chem. Eng. J., 1975, 21, 985-996.
20. Menon, G.; Ghadially, R. Morphology of lipid alterations in the epidermis: a review. Microvas. Res. Tech., 1997, 37, 180-192.
21. Yardley, H.J.; Summerly, R. Lipid composition and metabolism in normal and diseased epidermis. Pharmacol. Therap., 1981, 13, 357-383.
22. Lampe, M.A.; Burlingame, A.L.; Whitney, J.; Williams, M.L.; Brown, B.E.; Roitman, E.; Elias, P.M. Human stratum corneum lip-ids: characterization and regional variations. J. Lipid Res., 1983, 24, 120-130.
23. Combs, J.W. Maturation of rat mast cells. An electron microscope study. J. Cell. Biol., 1966, 31, 563-575.
24. Cowen, T.; Trigg, P.; Eady, R.A. Distribution of mast cells in human dermis: development of a mapping technique. Brit. J Derma-tol., 1979, 100, 635-640.
25. Williams, A.C.; Barry, B.W. Penetration enhancers, Adv. Drug Deliv. Rev., 2004, 56, 603-618.
26. Williams, A.C.; Barry, B.W. Terpenes and the lipid-protein- partitioning theory of skin penetration enhancement. Pharm. Res., 1991, 8, 17-24.
27. Hadgraft, J; Williams, D.G.; Allan, G. Azone: mechanisms of action and clinical effect. Walters, K.A.; Hadgraft, J.; Eds., Pharmaceutical Skin Penetration Enhancement, Marcel Dekker: New York, 1993; pp. 175-198.
28. Franz, T.J.; Lehman, P.A.; Kagy, M.K. In: Percutaneous Penetration Enhancers, Smith, E.W.; Maibach, H.I, Eds.; CRC Press: Boca Raton, FL, 1995; pp. 115-157.
29. Goates, C.Y.; Knutson, K. Enhanced permeation of polar compounds through human epidermis. I. Permeability and membrane structural changes in the presence of short chain alcohols. Biochem. Biophys, Acta, 1994, 1195, 169-179.
30. Menon, G.K.; Lee, S.H.; Roberts, M.S. In: Dermal Absorption and Toxicity Assessment; Roberts, M.S.; Walters, K.A, Eds.; Marcel Dekker: New York, 1998.
31. Roberts, M.S.; Cross, S.E.; Pellet, M.A. In: Dermatological and Transdermal Formulations, Walters, K.A, Ed.; Marcel Dekker: New York, 2000.
32. Kligman, A.M. Topical pharmacology and toxicology of di-methylsulfoxide. J. Am. Med. Assoc., 1965, 193, 796.
33. Southwell, D.; Barry, B.W. Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols and caffeine. J. Invest. Dermatol., 1983, 80, 507-515.
34. Phillips, C.A.; Michniak, B.B. Topical application of Azone analogs to hairless mouse skin: a histopathological study. Int. J. Pharm., 1995, 125, 63-71.
35. Jungbauer, F.H.W.; Coenraads, P.J.; Kardaun, S.H. Toxic hygroscopic contact reaction to N-methyl-2-pyrrolidone. Contact. Dermatitis., 2001, 45, 303-304.
36. Tupker, R.A.; Pinnagoda, J.; Nater, J.P. The transient and cumulative effect of sodium lauryl sulphate on the epidermal barrier assessed by transepidermal water loss: inter-individual variation. Acta. Derm. Venereol., 1990, 70, 1-5.
37. Kurihara-Bergstrom, T.; Knutson, K.; Noble, L.J.D.; Goates, C.Y. Percutaneous absorption enhancement of an ionic molecule by etha-nol-water systems in human skin. Pharm. Res., 1990, 7, 762-766.
38. Aqil, M.; Ahad, A.; Sultana, Y.; Ali, A. Status of terpenes as skin penetration enhancers. Drug Discov. Today, 2007, 12, 1061-1067.
39. Goldstein, I.; Payton, T.R.; Schechter, P.J. A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (topiglan) for the in-office treatment of erectile dysfunction. Adult Urol., 2001, 57, 301-305.
40. Berner, B.; John, V.A. Pharmacokinetic characterization of transder-mal delivery systems. Clin. Pharmacokinet., 1994, 126, 121-134.
41. tm augments stimulation of scalp hair growth by topical minoxidil in the balding stumptail macaque. Skin Pharmacol., 1995, 8, 221-228.
42. Morganti, F.; Bramanti, E.; Solaro, R.; Benedetti, E.; Chiellini, E.; Nannipieri, E.; Narducci, P.; Krauser, S.F.; Samour, C.M. Thermal and Spectroscopic Characterization of Interactions between 2-Nonyl-1,3-Dioxolane and Stratum Corneum Components. J. Bio-act. Compat. Polym., 1999, 14, 162-177.
43. Monti, D.; Saettone, M.F.; Giannaccini, B.; Galli-Angeli, D. Enhancement of transdermal penetration of dapiprazole through hairless mouse skin. J. Control. Release, 1995, 33, 71-77.
44. Maghraby, G.M.M.E.; Campbell, M.; Finnin, B.C. Mechanisms of action of novel skin penetration enhancers: Phospholipid versus skin lipid liposomes. Int. J. Pharm., 2005, 305, 90-104.
45. Harris, W.T.; Tenjarla, S.N.; Holbrook, J.M.; Smith, J.; Mead, C.; Entrekin, J. n-pentyl N-acetylprolinate. A new skin penetration enhancer. J. Pharm. Sci., 1995, 84, 640-642.
46. Tenjarla, S.N.; Kasina, R.; Puranajoti, P.; Omar, M.S.; Harris, W.T. Synthesis and evaluation of N-acetylprolinate esters-novel skin penetration enhancers. Int. J. Pharm., 1999, 192, 147-158.
47. Ghafouriana, T.; Zandasrar, P.; Hamishekar, H.; Nokhodchi, A. The effect of penetration enhancers on drug delivery through skin: a QSAR study. J. Control. Release, 2004, 99, 113-125.
48. Fincher, T.K.; Yoo, S.D.; Player, M.R.; Sowell, J.W.; Michniak, B.B. In vitro evaluation of a series of N-dodecanoyl-L- amino acid methyl esters as dermal penetration enhancers. J. Pharm. Sci., 1996, 85, 920-923.
49. Akimoto, T.; Nagase, Y. Novel transdermal drug penetration enhancer: synthesis and enhancing effect of alkyldisiloxane compounds containing glucopyranosyl group. J. Control. Release, 2003, 88, 243-252.
50. Akimoto, T.; Kawahara, K.; Nagase, Y.; Aoyagi, T. Preparation of oligodimethylsiloxanes with sugar moiety at a terminal group as a transdermal penetration enhancer. Macromol. Chem. Phys., 2000, 201, 2729-2734.
51. Aoyagi, T.; Nakamura, T.; Yabuchi, Y.; Nagase, Y. Novel silicones for transdermal therapeutic system III. Preparation of pyridinio or ammonio-polydimethylsiloxanes terminated and the evaluation as transdermal penetration enhancers. Polymer, 1992, 24, 545-553.
52. Aoyagi, T.; Akimoto, T.; Nagase, Y. Novel silicones for transder-mal therapeutic system, 4. Modified route to prepare oligodimeth-ylsiloxane containing a cationic end-group, and its property as transdermal penetration enhancer. Macromol. Chem. Phys., 1992, 193, 2821-2828.
53. Aoyagi, T.; Tadenuma, R.; Nagase, Y. Novel silicones for trans-dermal therapeutic system, 6. Preparation of oligodimethylsiloxane containing 2-pyrrolidone moiety as a terminal group and its enhancing effect on transdermal drug penetration. Macromol. Chem. Phys., 1996, 197, 677-686.
54. Hrabalek, A.; Dolezal, P.; Vavrova, K.; Zbytovska, J.; Holas, T.; Klimentova, J.; Novotny, J. Esters of 6-aminohexanoic acid as skin permeation: The effect of branching in the alkanol moiety. J. Pharm. Res., 2005, 94, 1494-1499.
55. Klimentova, J.; Hrabalek, A.; Vavrova, K.; Holas, T.; Kroutil, A. Synthesis and transdermal penetration-enhancing activity of carbonic and carbamic acid esters-Comparison with transkarbam 12. Bioorg. Med. Chem. Lett., 2006, 16, 1981-1984.
56. Klimentova, J.; Kosak, P.; Vavrova, K.; Holas, T.; Novotny, J.; Hra-balek, A. Transkarbams with terminal branching as transdermal permeation enhancers. Bioorg. Med. Chem. Lett., 2008, 18, 1712-1715.
57. Holas, T.; Vavrova, K.; Sima, M.; Klimentova, J.; Hrabalek, A. Synthesis and transdermal permeation-enhancing activity of carbonate and carbamate analogs of Transkarbam 12. Bioorg. Med. Chem., 2006, 14, 7671-7680.
58. Vavrova, K.; Lorencova, K.; Klimentova, J.; Novotny, J.; Holy, A.; Hrabalek, A. Transdermal and dermal delivery of adefovir: Effects of pH and permeation enhancers. Eur. J. Pharm. Biopharm., 2008, 69, 597-604.
59. Stoughton, R.B.; Fritsch, W. Influence of dimethylsulfoxide (DMSO) on human percutaneous absorption. Arch. Dermatol., 1964, 90, 512-517.
60. Kurihara-Bergstrom, T.; Flynn, G.L.; Higuchi, W.I. Physicochemi-cal study of percutaneous absorption enhancement by dimethyl sul-foxide: kinetic and thermodynamic determinants of dimethyl sul-foxide mediated mass transfer of alkanols. J. Pharm, Sci., 1986, 75, 479-486.
61. Barry, B.W. Mode of action of penetration enhancers in human skin. J. Control Release, 1987, 6, 85-97.
62. Skog, E.; Wahlberg, J.E. Effect of dimethyl sulfoxide on skin. A macroscopic and microscopic investigation on human skin. Acta Derm. Venereol., 1967, 47, 426-434.
63. Montes, L.F.; Day, J.L.; Wand, C.J.; Kennedy, L. Ultrastructural changes in the horny layer following local application of dimethyl sulfoxide. J. Invest. Dermatol., 1967, 48, 184-196.
64. Shackleford, J.M.; Yielding, K.L. Ultrastructural studies of barrier restoration in epidermis of hairless mice following dimethyl sulfox-ide application. J. Cutane. Pathol., 1984, 11, 259-268.
65. Kim, N.; El-Khalili, M.; Henary, M.M.; Strekowski, L.; Michniak, B.B. Percutaneous penetration enhancement activity of aromatic S,S-dimethyliminosulfuranes. Int. J. Pharm., 1999, 187, 219-229.
66. Song, Y.; Xiao, C.; Mendelsohn, R.; Zheng, T.; Strekowski, L.; Michniak, B. Investigation of iminosulfuranes as novel transdermal penetration enhancers: enhancement activity and cytotoxicity. Pharm, Res., 2005, 22, 1918-1925.
67. Burch, C.P.; Chandrasekaran, S.; Henary, M.M.; Spring, A.; Strekowski, L.; Smith, J.C. An investigation of the interaction of iminosulfurane transdermal penetration enhancers with model skin preparations using NMR spectroscopy. Int. J. Pharm., 2009, 373, 48-54.
68. Park, Y.H.; You, E.S.; Kim, W.B.; Lee, S.S. DA-5018, a novel vanilloid type analgesic. Arch. Pharmacal. Res., 1997, 20, 93-95.
69. Bertrant, C.; Nadelm, J.A.; Graf, P.D.; Geppetti, P. Capsaicin increases airflow resistance in guinea pigs in vivo by activating both NK2 and NK1 tachykinin receptor. Am. Rev. Respir. Dis., 1993, 148, 909-914.
70. Huang, Y.B.; Lin, Y.H.; Lu, T.M.; Wang, R.J.; Tsai, Y.H.; Wu, P.C. Transdermal delivery of capsaicin derivative-sodium noni-vamide acetate using microemulsions as vehicles. Int. J. Pharm., 2008, 349, 206-211.
71. Degim, I.T.; Uslu, A.; Hadgraft, J.; Atay, T.; Akay, C.; Cevheroglu, S. The effects of Azone and capsaicin on the permeation of naproxen through human skin. Int. J. Pharm., 1999, 179, 21-25.
72. ® pre-treatment fails to decrease the pain induced by 1% topical cap-saicin. Pain, 1999, 80, 637-642.
73. Fang, J.Y.; Wu, P.C.; Huang, Y.B.; Tsai, Y.H. In vitro permeation study of capsaicin and its synthetic derivatives from ointment bases using various skin types. Int. J. Pharm., 1995, 126, 119-128.
74. Hayes, A.G.; Orford, A.; Reynolds, M.; Skingler, A.H.; Skingler, M.; Smith, C.; Tyers, M.B. The effects of a series of capsaicin analogues on nociception and body temperature in the rat. Life Sci., 1984, 34, 154-156.
75. Wu, P-C.; Chang, J-S.; Huang, Y-B.; Chai, C-Y.; Tsai, Y-H. Evaluation of percutaneous absorption and skin irritation of keto-profen through rat skin: in vitro and in vivo study. Int. J. Pharm., 2001, 222, 225-235.
76. Huang, Y-B.; Wang, R-J.; Chang, J-S.; Tsai, Y-H.; Wu, P-C. Evaluation of ketoprofen formulations via penetration rate and irritation in vivo study. Int. J. Pharm., 2007, 339, 47-51.
77. Lee, B-J.; Lee, T-S.; Cha, B-J.; Kim, S-H.; Kim, W-B. Percutaneous absorption and histopathology of a poloxamer-based formulation of capsaicin analog. Int. J. Pharm., 1997, 159, 105-114.
78. Cha, B.J.; Lee, E.D.; Kim, W.B.; Chung, S-J.; Lee, M-H.; Shim, C-K. Enhanced Skin Permeation of a New Capsaicin Derivative (DA-5018) from a binary vehicle system composed of isopropyl-myristate and ethoxydiglycol. Arch. Pharm. Res., 2001, 24, 224-228.
79. Fang, J-Y.; Wu, P-C.; Huang, Y-B.; Tsai, Y-H. In vivo percutaneous absorption of capsaicin, nonivamide and sodium nonivamide acetate from ointment bases Pharmacokinetic analysis in rabbits. Int. J. Pharm., 1996, 128, 169-177.
80. Fang, J-Y.; Fang, C-L.; Huang, Y-B.; Tsai, Y-H. Transdermal iontophoresis of sodium nonivamide acetate. III. Combined effect of pretreatment by penetration enhancers. Int. J. Pharm., 1997, 149, 183-193.
81. Fang, J-Y.; Kuo, C-T.; Huang, Y-B.; Wu, P-C.; Tsai, Y-H. Trans-dermal delivery of sodium nonivamide acetate from volatile vehicles: effects of polymers. Int. J. Pharm., 1999, 176, 157-167.
82. Zhang, C.F.; Yang, Z.L.; Luo, J.B.; Zhu, Q.H.; Zhao, H.N. Effects of cinnamene enhancers on transdermal delivery of ligustrazine hy-drochloride. Eur. J. Pharm. Biopharm., 2007, 67, 413-419.
83. Camilla, K.S.; Caroline, A.M.; Eiram, N.E.; Alan, T.S.S.; Sharon, A.M.H. Human Skin absorption and metabolism of the contact allergens, cinnamic aldehyde and cinnamic alcohol. Toxic. Appl. Pharmacol., 2000, 168, 189-199.
84. Ni, Y.; Turner, D.; Yates, K.M.; Tizard, I. Isolation and characterization of structural components of Aloe Vera L. leaf pulp. Int. Im-munopharmacol., 2004, 4, 1745-1755.
85. Meadows, T.P. Aloe as a humectant in new skin preparations. Cosmet. Toiletries, 1980, 95, 51-56.
86. Cole, L.; Heard, C. Skin permeation enhancement potential of Aloe Vera and a proposed mechanism of action based upon size exclusion and pull effect. Int. J. Pharm., 2007, 333, 10-16.
87. Li, W.; Shen, Q.; Li, W. The Effect of clove oil on the transdermal delivery of ibuprofen in the rabbit by in vitro and in vivo methods. Drug Dev. Ind. Pharm., 2007, 33, 1369-1374.
88. Jain, R.; Aqil, M.; Ahad, A.; Ali, A.; Khar, R.K. Basil oil is a promising skin penetration enhancer for transdermal delivery of labe-tolol hydrochloride. Drug Dev. Ind. Pharm., 2008, 34, 384-389.
89. Lashmar, U.T.; Hadgraft, J.S.; Thomas, N. Topical application of penetration enhancers to the skin of nude mice-a histopathological study. J. Pharm. Pharmacol., 1989, 41, 118-122.
90. Karande, P.; Jain, A.; Mitragotri, S. Discovery of transdermal penetration enhancers by high-throughput screening, Nat. Biotech., 2004, 22, 192-197.